Сorrelation between age and the intensity of the post-vaccination humoral immune response in individuals passed COVID-19

Q4 Immunology and Microbiology Immunologiya Pub Date : 2022-01-01 DOI:10.33029/0206-4952-2022-43-5-583-592
A. I. Andreev, I. V. Andreev, K.O. Nechay, D. R. Esaulova, O. S. Baklakova, V.I. Vecherko, I. Shilovskiy, I. Kofiadi, G. Gudima, А. Martynov, V. Smirnov, D. Kudlay, M. Khaitov
{"title":"Сorrelation between age and the intensity of the post-vaccination humoral immune response in individuals passed COVID-19","authors":"A. I. Andreev, I. V. Andreev, K.O. Nechay, D. R. Esaulova, O. S. Baklakova, V.I. Vecherko, I. Shilovskiy, I. Kofiadi, G. Gudima, А. Martynov, V. Smirnov, D. Kudlay, M. Khaitov","doi":"10.33029/0206-4952-2022-43-5-583-592","DOIUrl":null,"url":null,"abstract":"Introduction. Despite widespread vaccination against COVID-19 worldwide, the epidemiological situation remains insufficient. The appearance of mutant forms of SARS-CoV-2 with increased virulence causes new waves of COVID-19 morbidity. The virus variability can cause the reduction of the vaccination effectiveness. In this regard, it is important to study the dynamics of post-vaccination immunity, its features in various population groups, as well as the relationship between post-infectious and post-vaccination immunity. The study continues a series of researches of the features of SARS-CoV-2-specific immunity in COVID-19 convalescents and recipients of the <<Sputnik V>> vaccine. The aim of the study - assessment of the intensity of the SARS-CoV-2-specific immune response in different age groups of people passed COVID-19 and subsequently vaccinated with <<Sputnik V>>. Material and methods. With the help of EIA, the level of IgG antibodies to S-antigen and N-antigen of SARS-CoV-2 was studied in 155 samples of blood sera of individuals (men and women) aged 18 to 70 years who passed COVID-19 and after 6 month of recovery underwent a full course of vaccination with <<Sputnik V>>. Samples from individuals of the following age groups were examined: from 18 to 35, from 35 to 45, from 45 to 55, from 55 to 65, from 65 to 70 years. Results. In all the examined age groups of individuals passed COVID-19 and then vaccinated with <<Sputnik V>>, there was a high level of IgG antibodies to SARS-CoV-2 S-protein (positivity coefficient 8.1 and higher). The level of IgG antibodies to the N-protein in more than half of the cases was lower than positive values among all the subjects. Conclusion. The study showed that individuals passed COVID-19 and then vaccinated with <<Sputnik V>>, regardless of age, have intense post-vaccination humoral immunity. Copyright © 2022 Meditsina Publishers. All rights reserved.","PeriodicalId":38750,"journal":{"name":"Immunologiya","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunologiya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33029/0206-4952-2022-43-5-583-592","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Despite widespread vaccination against COVID-19 worldwide, the epidemiological situation remains insufficient. The appearance of mutant forms of SARS-CoV-2 with increased virulence causes new waves of COVID-19 morbidity. The virus variability can cause the reduction of the vaccination effectiveness. In this regard, it is important to study the dynamics of post-vaccination immunity, its features in various population groups, as well as the relationship between post-infectious and post-vaccination immunity. The study continues a series of researches of the features of SARS-CoV-2-specific immunity in COVID-19 convalescents and recipients of the <> vaccine. The aim of the study - assessment of the intensity of the SARS-CoV-2-specific immune response in different age groups of people passed COVID-19 and subsequently vaccinated with <>. Material and methods. With the help of EIA, the level of IgG antibodies to S-antigen and N-antigen of SARS-CoV-2 was studied in 155 samples of blood sera of individuals (men and women) aged 18 to 70 years who passed COVID-19 and after 6 month of recovery underwent a full course of vaccination with <>. Samples from individuals of the following age groups were examined: from 18 to 35, from 35 to 45, from 45 to 55, from 55 to 65, from 65 to 70 years. Results. In all the examined age groups of individuals passed COVID-19 and then vaccinated with <>, there was a high level of IgG antibodies to SARS-CoV-2 S-protein (positivity coefficient 8.1 and higher). The level of IgG antibodies to the N-protein in more than half of the cases was lower than positive values among all the subjects. Conclusion. The study showed that individuals passed COVID-19 and then vaccinated with <>, regardless of age, have intense post-vaccination humoral immunity. Copyright © 2022 Meditsina Publishers. All rights reserved.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Сorrelation年龄与COVID-19感染者接种疫苗后体液免疫反应强度之间的关系
介绍。尽管在世界范围内广泛接种COVID-19疫苗,但流行病学形势仍然不足。具有增强毒力的SARS-CoV-2突变型的出现导致新一波COVID-19发病率。病毒的变异可导致疫苗接种效果的降低。因此,研究疫苗接种后免疫动态、不同人群的免疫特征以及感染后免疫与疫苗接种后免疫的关系具有重要意义。这项研究是对COVID-19恢复期和>疫苗接种者的sars - cov -2特异性免疫特征的一系列研究的继续。本研究的目的是评估不同年龄组感染COVID-19并随后接种>疫苗的人的sars - cov -2特异性免疫反应强度。材料和方法。应用EIA对155例18 ~ 70岁感染COVID-19并在康复6个月后接种>全程疫苗的个体(男、女)血清进行了SARS-CoV-2 s抗原和n抗原IgG抗体水平的研究。研究人员检查了以下年龄组的样本:18至35岁,35至45岁,45至55岁,55至65岁,65至70岁。结果。在感染COVID-19并接种>疫苗的所有被检查年龄组中,SARS-CoV-2 s蛋白IgG抗体水平均较高(阳性系数为8.1及以上)。半数以上患者的n蛋白IgG抗体低于阳性水平。结论。该研究表明,感染COVID-19并接种>疫苗的个体,无论年龄大小,在接种疫苗后都具有强烈的体液免疫。版权所有©2022新浪传媒出版社。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Immunologiya
Immunologiya Immunology and Microbiology-Immunology
CiteScore
1.90
自引率
0.00%
发文量
31
期刊最新文献
Severe course of HAE and a new variant of the SERPING1 gene in a large Caucasian family MIR 19® – world first specific antiviral drug for COVID-19 treatment: development and preclinical studies Cellular and humoral responses to SARS-CoV-2 (omicron variant) in children and adolescents with pulmonary tuberculosis Methodology for evaluation of the level of IgG antibodies against different SARS-CoV-2 proteins using multiplex immunofluorescence analysis Comparison of transcriptional profiles of human macrophages activated by agonists of NOD1 and TLR4 receptors
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1